ADMA Biologics CEO Adam Grossman Sells $1.76 Million of Stock After Option Exercise
ADMA Biologics, Inc. President and Chief Executive Officer Adam S. Grossman sold 147,000 shares of ADMA common stock for $1,764,000 on Nov. 5, 2026 after exercising employee stock options, according to a Form 4 filed early Friday.
The filing shows an option exercise of 105,000 shares at $5.40 per share, followed by open-market sales of 105,000 shares and an additional 42,000 shares, all at $12.00 per share. The Form 4 marks the trades as made under a Rule 10b5-1 trading plan. Grossman also serves as a director.
After the transactions, Grossman directly owned 2,070,777 ADMA shares.
Sources
- ADMA Biologics Form 4 for CEO Adam S. Grossman option exercise and sales, filed Nov. 6, 2026 (accession 0001140361-26-042166)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.